Macular Degeneration

Oraya therapy for wet macular degeneration

Carl Zeiss agrees collaboration with Oraya

Germany’s Carl Zeiss Meditec said late on Monday it had signed a deal with Oraya Therapeutics under which it will provide funding to the U.S.-based firm for its growth strategy for up to two years

read more: Carl Zeiss agrees collaboration with Oraya


The Oraya therapy is offered, among others, by the University Eye Clinic of Lübeck

Zur Übersicht Oraya-Therapie bei feuchter Makuladegeneration